Biota no longer needs big pharma for lani stockpiling but it does need them for seasonal use. No rush to license. I'd wait till they get approval from the FDA before signing any deal. Funding has massively benefited BTA's negotiating position.
BTA Price at posting:
$1.40 Sentiment: Buy Disclosure: Held